Robotic Catheter Systems is Likely to Witness Significant Growth due to their Advantages

The major drivers of the market are the rising prevalence of cardiovascular diseases and reduced occupational hazards for cardiologists. These systems are medical robots that work through a joy stick or a remote to perform various diagnostic and therapeutic procedures, such as the stent implantation, myocardial biopsy, ablation, and coronary angiogram, among others.

The robotic catheter systems market is categorized into Middle East & Africa, Latin America, Asia-Pacific, Europe, and North America based on region. In 2018, the highest revenue generator in the market was North America, and in the forecast period as well, it would continue to dominate the market, in terms of revenue.  The major driving factors of the regional market are the high adoption of these systems for cardiovascular diagnostic and therapeutic procedures in hospitals and clinics and the large presence of key manufacturers.

The robotic catheter systems market is witnessing the trend of digitization of instruments, which has been a key factor in the evolution of integrated and automated cardiovascular interventional labs. The advancements in the robotic technology are taking place rapidly, which, in turn, is helping hospitals cut down on catheterization lab costs, particularly in remote areas. The operational efficiency of cath labs has massively improved due to the commercialization of such systems.  Even though these systems are pretty expensive, they are being heavily deployed owing to the advantages they offer over conventional catheterization procedures.

Access Report Summary - Robotic Catheter Systems Market Segmentation Analysis

With the technological advancements, the robotic catheter systems market would witness remarkable growth due to the extensive testing of these systems in the clinical trials. Catheterized cardiovascular procedures, such as catheter ablation, are popularly used in modern medicine, but robot-assisted catheterized procedures have not become as popular as their conventional counterparts due to the scarcity of skilled professionals. Companies, such as CorPath, Amigo, Sensei, and Niobe are commercializing robot catheterization systems, which may contribute in the demand for training people for operating the technology, thereby making them popular among patients and surgeons.

Hence, the market for robotic catheter systems is set to advance in the forecast period as the requirement for safer technologies for carrying out cardiovascular procedures is rising.